QuantaMatrix
develops and commercializes molecular and cellular based drugs for the treatment of Tuberculosis, infectious disease and cancer... Read moreQuantaMatrix
develops and commercializes molecular and cellular based drugs for the treatment of Tuberculosis, infectious disease and cancer... Read more
Annual Revenue
$1.6M
Employees
93
News
Dec 16, 2024
Korea Biomedical Review
QuantaMatrix: QuantaMatrix to launch Alzheimer's early detection test as non-reimbursable service
Aug 21, 2024
PharmaTimes
QuantaMatrix: AMR testing technology from QuantaMatrix backed by research paper in Nature
Aug 19, 2024
Medical Device Network
QuantaMatrix: QuantaMatrix unveils "world's fastest" AMR test to tackle sepsis
Jul 25, 2024
Korea Biomedical Review
QuantaMatrix: QuantaMatrix shares shoot up 30% after Nature publication on super-fast sepsis diagnostic technology
Aug 31, 2023
Korea Biomedical Review
QuantaMatrix: QuantaMatrix wins 11 million bid to supply microbiology diagnostics to French public hospitals
Dec 15, 2021
centralcharts
Press Release: QuantaMatrix : Limbach Group adopts QuantaMatrix dRAST in routine clinical use
Dec 08, 2020
PR Newswire Asia
QuantaMatrix: QuantaMatrix to Debut on KOSDAQ on Wednesday (12/9) after raising $40.2mn in IPO, at $23.57
Dec 08, 2020
PR Newswire
Press Release: QuantaMatrix : QuantaMatrix to Debut on KOSDAQ on Wednesday (12/9) after raising $40.2mn in IPO, at $23.57
Sep 07, 2020
Global University Venturing
QuantaMatrix: QuantaMatrix to match up $71.8m IPO - Global University Venturing
Sep 03, 2020
The Korea Herald
QuantaMatrix: [Herald Interview] QuantaMatrix seeks October IPO for overseas entry
QuantaMatrix Competitors
1
2
3
4
5
6
7
8
9
10